The shortlist

Alternatives to Solaya MD

Solaya MD sits at No. 299 in our ranking with a Brief Score of 64. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Solaya MD.

Our top alternative

No. 1 here

Brief Score

94/100

Editorial rating

CoreAge Rx

CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

Semaglutide: From $79/mo
Annual offer: 12 months paid upfront, from $948.
Main site: from $99/mo; confirm the selected offer.
Full price details
From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo
Tirzepatide: From $129/mo
Annual offer: 12 months paid upfront, from $1,548.
Main site: from $149/mo; confirm the selected offer.
Full price details
From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo
Coverage: US only; restrictions by state, confirmed at intake

Visit CoreAge Rx CoreAge Rx vs Solaya MD →

More providers worth weighing

No. 11 · Grade B+

REMEVi

87/100

English- and Spanish-language GLP-1 care with four-week billing, published prepaid totals and no advertised dose upcharge.

Semaglutide: $199 / 4 weeks
24-week option: $954 upfront ($159 per four weeks).
Full price details
$199 every 4 weeks; $954 prepaid for 24 weeks ($159 per 4 weeks)
Coverage: 49 states and DC; excludes Louisiana
Price trend: new to the tracker, no prior reading

Visit Read the brief →

No. 14 · Grade B+

Vaylen

87/100

Prepaid GLP-1 plans with an oral option, but coverage and clinical-provider details need clarification.

Semaglutide: From $83/mo equivalent
12 months paid upfront; confirm the full charge.
Shorter plans have separate pricing.
Full price details
From $83/mo equivalent; 12 months prepaid
Coverage: Homepage says 50 states; terms say 49—confirm availability
Price trend: new to the tracker, no prior reading

Visit Read the brief →

No. 7 · Grade B

Sprout Health

86/100

A compounded GLP-1 provider with four-week and annual offers, plus a separate tablet-and-injection program whose advertised prices differ.

Semaglutide: $149 / 4 weeks
Annual option: $1,188 upfront ($99/mo equivalent).
Other landing page: $299/mo. Confirm your offer and billing terms.
Full price details
$149 every 4 weeks; annual plan $1,188 upfront ($99/mo equivalent). Separate GLP-1 landing page lists $299/mo
Coverage: Not disclosed
Price trend: new to the tracker, no prior reading

Visit Read the brief →

FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.

No. 8 · Grade B

MadeMed

86/100

MadeMed publishes quarterly and six-month prices for injectable and sublingual treatment; the full term is prepaid, and supply timing needs confirmation.

Semaglutide: $239/mo injectable
Quarterly prepay: $717 upfront; no monthly plan.
Sublingual: $219/mo, $657 upfront quarterly. Six-month options cost less.
Full price details
$239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option
Coverage: Availability varies by treatment and state; confirm the selected product before prepaying
Price trend: price stable

Visit Read the brief →

No. 21 · Grade B

Curex

86/100

Curex offers compounded injections and tablets, but its introductory offers, annual prices and refund promises need to be matched to the terms you accept.

Semaglutide: Confirm the selected offer
Rate sheet: $299 monthly or $2,388 annually ($199/mo equivalent).
Separate first-month offer from $49; renewal quote requires confirmation.
Full price details
Conflicting published offers: rate sheet $299/month or $2,388 annual prepayment ($199/mo equivalent); separate offer from $49 first month
Coverage: All 50 states advertised; California oral tablets only, no injections
Price trend: new to the tracker, no prior reading

Visit Read the brief →

FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.

No. 23 · Grade B

Telos Rx

85/100

Compounded injectable and sublingual options with advertised starting prices; confirm the complete plan, billing interval and renewal amount before choosing.

Semaglutide: From $99/mo injectable — a floor, not a rate: Telos publishes "as low as $99" and says the price depends on plan length, which is shown only inside the intake
Coverage: Not publicly listed
Price trend: price stable

Visit Read the brief →

No. 26 · Grade B

BetterMe Rx

85/100

BetterMe Rx includes dose adjustments and publishes its pharmacy network, but the selected plan needs a current renewal quote and clear cancellation terms.

Semaglutide: Confirm current price
Earlier listing: $199/mo (original check date not recorded).
Confirm the medication, billing term and full charge before paying.
Full price details
Compounded semaglutide offered. Current medication quote unknown; earlier listing: $199/mo
Coverage: All 50 states
Price trend: price stable

Visit Read the brief →

No. 28 · Grade B

TeleCareSpot

85/100

TeleCareSpot publishes monthly medication programs and state exclusions, but its refund terms still contain unedited sample-policy language.

Semaglutide: From $299/mo
Monthly supply if prescribed; support and delivery where available. Confirm any separate consultation charge.
Full price details
From $299/month; monthly supply if prescribed, support and delivery where available
Coverage: Excludes Alaska, Mississippi and New Jersey; confirm selected treatment eligibility
Price trend: price stable

Visit Read the brief →

Read our full Solaya MD brief →All comparisons →

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.